These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27155964)

  • 1. Clinical status of a cohort of patients with type 1 diabetes diagnosed more than 2 decades before. Results of a specific clinical follow-up program.
    Amor AJ; Cabrer M; Giménez M; Vinagre I; Ortega E; Conget I
    Endocrinol Nutr; 2016; 63(7):339-44. PubMed ID: 27155964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and clinical profile of metabolic syndrome among type 1 diabetes mellitus patients in southern India.
    Billow A; Anjana RM; Ngai M; Amutha A; Pradeepa R; Jebarani S; Unnikrishnan R; Michael E; Mohan V
    J Diabetes Complications; 2015 Jul; 29(5):659-64. PubMed ID: 25899474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes-specific variables associated with quality of life changes in young diabetic people: the type 1 diabetes Registry of Turin (Italy).
    Trento M; Panero F; Porta M; Gruden G; Barutta F; Cerutti F; Gambino R; Perotto M; Cavallo Perin P; Bruno G;
    Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):1031-6. PubMed ID: 23466181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.
    Olsen B; Johannesen J; Fredheim S; Svensson J;
    Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.
    Levy-Shraga Y; Lerner-Geva L; Modan-Moses D; Graph-Barel C; Mazor-Aronovitch K; Boyko V; Pinhas-Hamiel O
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):225-9. PubMed ID: 23329580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
    Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost-effectiveness analysis of continuous subcutaneous insulin injection versus multiple daily injections in type 1 diabetes patients: a third-party US payer perspective.
    St Charles M; Lynch P; Graham C; Minshall ME
    Value Health; 2009; 12(5):674-86. PubMed ID: 19171006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous Subcutaneous Insulin Infusion in Neonates and Infants Below 1 Year: Analysis of Initial Bolus and Basal Rate Based on the Experiences from the German Working Group for Pediatric Pump Treatment.
    Kapellen TM; Heidtmann B; Lilienthal E; Rami-Merhar B; Engler-Schmidt C; Holl RW
    Diabetes Technol Ther; 2015 Dec; 17(12):872-9. PubMed ID: 26509360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of autoimmune diseases and microangiopathy in children with diabetes type 1 over the years 2000-2010].
    Głowińska-Olszewska B; Ordowska U; Golonko M; Tobiaszewska M; Florys B; Jabłońska J; Otocka A; Łuczyński W; Zasim A; Jakubowska E; Michalak J; Bossowski A
    Pediatr Endocrinol Diabetes Metab; 2013; 19(2):51-7. PubMed ID: 25612636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus].
    Hasselmann C; Bonnemaison E; Faure N; Mercat I; Bouillo Pépin-Donat M; Magontier N; Chantepie A; Labarthe F
    Arch Pediatr; 2012 Jun; 19(6):593-8. PubMed ID: 22584198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK.
    Roze S; Valentine WJ; Zakrzewska KE; Palmer AJ
    Diabet Med; 2005 Sep; 22(9):1239-45. PubMed ID: 16108855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic control of type 1 diabetic patients followed at the University Children's Hospital in Berne: have we reached the goal?
    Tonella P; Flück CE; Mullis PE
    Swiss Med Wkly; 2010; 140():w13057. PubMed ID: 20648399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thailand diabetes registry project: type of diabetes, glycemic control and prevalence of microvascular complications in children and adolescents with diabetes.
    Likitmaskul S; Wacharasindhu S; Rawdaree P; Ngarmukos C; Deerochanawong C; Suwanwalaikorn S; Chetthakul T; Bunnag P; Kosachunhanun N; Plengvidhaya N; Leelawatana R; Krittiyawong S; Benjasuratwong Y; Pratipanawatr T
    J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S10-6. PubMed ID: 17715829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycaemic variability in paediatric patients with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) or multiple daily injections (MDI): a cross-sectional cohort study.
    Schreiver C; Jacoby U; Watzer B; Thomas A; Haffner D; Fischer DC
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):641-7. PubMed ID: 23134485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous subcutaneous insulin infusion preserves axonal function in type 1 diabetes mellitus.
    Kwai N; Arnold R; Poynten AM; Lin CS; Kiernan MC; Krishnan AV
    Diabetes Metab Res Rev; 2015 Feb; 31(2):175-82. PubMed ID: 25066412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with continuous subcutaneous insulin infusion is associated with lower arterial stiffness.
    Rosenlund S; Theilade S; Hansen TW; Andersen S; Rossing P
    Acta Diabetol; 2014 Dec; 51(6):955-62. PubMed ID: 25274393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant retinopathy in young-onset type 2 vs. type 1 diabetes: a clinical observation.
    Song SH
    Int J Clin Pract; 2016 Oct; 70(10):853-860. PubMed ID: 27028787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use and Effectiveness of Continuous Subcutaneous Insulin Infusion (CSII) and Multiple Daily Insulin Injection Therapy (MIT) in Children, Adolescents and Young Adults with Type 1 Diabetes Mellitus.
    Schiel R; Burgard D; Perenthaler T; Stein G; Kramer G; Steveling A
    Exp Clin Endocrinol Diabetes; 2016 Feb; 124(2):99-104. PubMed ID: 26895277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.